Abstract
Objective To analyze the changes of carotid atherosclerotic plaque and levels of serum high-sensitivity C-reactive protein (hs-CRP) in patients with acute cerebral infarction treated with risuvastatin were analyzed. Methods A total of 109 patients with acute cerebral infarction treated in the hospital from January 2016 to June 2017 were divided into two groups by random digital table, 54 cases in control group were treated with atorvastatin, and 55 cases in observation group were treated with rosuvastatin. The changes of hs-CRP, blood lipid and carotid atherosclerotic plaque thickness were compared between the two groups after treatment. Results After treatment, total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-C), hs-CRP and carotid atherosclerotic plaque thickness of the observation group were lower than those of the control group (P<0.05). Conclusions Resuvastatin can effectively reduce inflammatory factors and blood lipid levels in patients with acute cerebral infarction and reverse atherosclerotic plaque. Key words: Reshuvastatin; Acute cerebral infarction; High sensitivity C-reactive protein; Carotid atherosclerotic plaque
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
